The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective observational study of nutritional and immunological indices as predictive biomarkers of response to immune checkpoint inhibitors in non-small cell lung cancer (ICI-PREDICT study).
 
Shinkichi Takamori
No Relationships to Disclose
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Masafumi Yamaguchi
Speakers' Bureau - AstraZeneca Japan; Bristol-Myers Squibb K.K.; Chugai Pharma; Lilly; MSD K.K.
 
Masahide Mori
Speakers' Bureau - Abbvie; Astrazeneca; Boehringer Ingelheim; Chugai Pharma; Daiici-Sankyo; Kyowa-kirin; Lilly; MSD; Nihonkayaku; Ono pharmacoceutical; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma (Inst)
 
Shoichi Kuyama
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Company; Chugai Pharma; DAIICHI SANKYO COMPANY, LIMITED.; Hisamitsu Pharmaceutical; Kyowa Kirin Co., Ltd; Lilly Japan; MSD; Nippon Kayaku; Pfizer; Taiho Pharmaceutical
 
Masahide Oki
Speakers' Bureau - AMCO; AstraZeneca Japan; Canon Medical Systems Corp.; Chugai Pharma; Fujifilm Corp.; GlaxoSmithKline K.K.; Intuitive Surgical; Kaneka Medix Corp.; Lilly Japan; Merck; Merck Sharp & Dohme; Merit Medical Japan K.K.; Nippon Boehringer Ingelheim; Novartis; Olympus Marketing, Inc.; Sanofi
Research Funding - Abbvie; AstraZeneca Japan; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline K.K.; Janssen; Kaneka Medix Corp.; Merck Sharp & Dohme; Ono Pharmaceutical; PAREXEL; Sanofi
 
Yoshifumi Nishimura
No Relationships to Disclose
 
Katsumi Nakatomi
No Relationships to Disclose
 
Hidetoshi Yanai
No Relationships to Disclose
 
Noriaki Sukoh
No Relationships to Disclose
 
Nobuo Hatakeyama
No Relationships to Disclose
 
Toshiyuki Kita
No Relationships to Disclose
 
Keiichi Fujiwara
Honoraria - AstraZeneca Japan; Chugai Pharma; Lilly Japan; MSD K.K; Ono Pharmaceutical
 
Kenji Chibana
No Relationships to Disclose
 
Masaki Okamoto
No Relationships to Disclose
 
Mitsuhiro Takenoyama
No Relationships to Disclose